86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details


臨床試験数 : 1,205 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04266197
(ClinicalTrials.gov)
September 25, 202022/1/2020Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B StudyA Phase 2b, Open-label, Single Dose Study to Evaluated the Safety and Efficacy of RT234 on Exercise Parameters Assessed by Cardiopulmonary Exercise Testing (CPET) in Subjects With Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial HypertensionCombination Product: Drug: RT234 - vardenafil inhalation powder; Device: Axially Oscillating Sphere dry powder inhaler (AOS DPI)Respira Therapeutics, Inc.NULLRecruiting18 Years80 YearsAll86Phase 2United States;Serbia
2NCT05343637
(ClinicalTrials.gov)
July 30, 20194/4/2022A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial HypertensionA Phase 2a, Dose Escalation Study to Evaluate the Effect of RT234 on Cardiopulmonary Hemodynamics in Subjects With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionCombination Product: Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)Respira Therapeutics, Inc.NULLCompleted18 Years80 YearsAll14Phase 2Australia